Refine by
Emergency Care Articles & Analysis
33 news found
Entegrion Announces CE Mark for Point of Care System for Blood Coagulation Monitoring. Regulatory clearance makes Entegrion’s innovative point of care diagnostic instrument for viscoelastic coagulation testing available to clinicians in Europe. ...
An interview with the lead author from The American Journal of Sports Medicine, Effects of the New York State Concussion Management and Awareness Act (“Lystedt Law”) on Concussion-Related Emergency Health Care Utilization Among Adolescents, 2005-2015 (here). ...
Their responses included: Reducing IV restarts Less trauma to patients by reducing restart-related needlesticks Preserving patient veins for subsequent procedures Maintaining IV access in emergency and critical care situations, and when transporting patients Lowered costs due to less waste of IV supplies. ...
Oxygen is usually supplied through an oxygen generator combined with a nasal cannula and can be used at the initial referral level of the primary health care or health care system. The coronavirus pandemic has exposed the oxygen gap faced by many low - and middle-income countries. ...
He also served as the Vice-President of Primary Care & Specialty Marketing for Eisai Pharmaceuticals. Thomas graduated with a degree in Engineering from the University of Wisconsin-Madison. ...
“This acquisition supports our strategy to build a portfolio of products that improves the standard of care for patients suffering from critical and rare conditions.” Xermelo will be commercially available from SERB outside the US and Japan starting in July 2022. ...
The AscencioDx represents a new generation of point-of-care molecular diagnostic testing that enables highly accurate results in about 30 minutes. ...
Andrew Barofsky, President and CEO of RevMedx, Inc., stated, “CE Mark on our XGAUZE product now makes our entire portfolio available to emergency responders and surgeons in the European Union and around the world. ...
ByRevMedx
Until now, patients needing routine or emergent care required transportation by medical charter flight hundreds of miles away to either Timmins or Kingston, ON. ...
About SERB and BTG Specialty Pharmaceuticals Together, SERB and BTG are a growing specialty pharmaceutical company and a dedicated ally to healthcare providers treating patients with critical conditions, focusing on emergency care and rare diseases. For over 30 years we have made treating these complex and life-threatening conditions possible, supporting ...
BTG is a growing specialty pharmaceutical platform and a dedicated ally to healthcare providers treating patients with critical conditions, focusing on emergency care and rare diseases. For over 30 years we have made treating these complex and life-threatening conditions possible, supporting clinicians, healthcare systems and governments while offering hope to ...
About SERB and BTG Specialty Pharmaceuticals Together, SERB and BTG are a growing specialty pharmaceutical company and a dedicated ally to healthcare providers treating patients with critical conditions, focusing on emergency care and rare diseases. For over 30 years we have made treating these complex and life-threatening conditions possible, supporting ...
About SERB and BTG Specialty Pharmaceuticals Together, SERB and BTG are a growing specialty pharmaceutical platform and a dedicated ally to healthcare providers treating patients with critical conditions, focusing on emergency care and rare diseases. For over 30 years we have made treating these complex and life-threatening conditions possible, supporting ...
It provides advanced, state-of-the-art medical care, such as emergency medical care, cancer treatment and regenerative medicine, and also plays a significant role as a medical institution that assists the development of local medical services and accepts patients from remote areas in Hokkaido in cases of disasters. ...
As we continue to achieve regulatory milestones that broaden the availability of glucarpidase globally, we grow more excited for Voraxaze’s potential to improve the care of cancer patients around the world.” In August of 2020 BTG submitted a Marketing Authorisation Application for Voraxaze® (glucarpidase) with the European Medicines Agency (EMA) for the treatment ...
We are committed to the continued growth of VeinViewer® as a standard of care and are excited to partner with DO-PA Inc. as our authorized distributor for Turkey.DO-PA A.S. is one of the oldest medical distribution companies in Turkey and has experience in obstetrics, cardiovascular surgery, plastic and general surgery, aesthetics, emergency, and intensive ...
This is one of the latest extensions of VUNO’s ambition to leverage the full potential of AI to better orchestrate clinical workflows by empowering medical service providers to deliver patient-focused care. VUNO’s AI algorithm has been successfully validated for its improved clinical utility and efficiency in academic journals and clinical settings. ...
The Coala differs from other devices on the market because of the instant response and by reducing worries and anxiety related to palpitations, there is ability to help to decrease the need of unnecessary admissions to primary care and emergencies. The RedHeart findings suggest that direct ECG feedback improves a patient’s sense of control, security, and ...
The Neurescue device is designed to increase blood flow to the brain and heart during life-threatening emergencies such as cardiac arrest. Cardiac arrest is one of the leading causes of death around the world, killing 7 million to 9 million people a year. With standard care, 1 out of 10 people survive cardiac arrest. Neurescue, founded by Dr. ...
Vygon specializes in the development and commercialization of medical devices that are used by healthcare professionals in multiple clinical areas, in particular intravascular therapies, anesthesia and emergency care, as well as cardiology and vascular surgery. Oncomfort has created its digital therapy to reduce pain and anxiety for patients in these clinical ...